Amneal (AMRX) major holder gets 12.8M shares in $375M Kashiv purchase
Rhea-AI Filing Summary
Amneal Pharmaceuticals, Inc. reported that reporting person Tushar Bhikhubhai Patel, a greater-than-10% owner, indirectly acquired 12,763,469 shares of Amneal Class A common stock. The shares are held through limited liability companies controlled by family trusts.
The acquisition occurred on August 10, 2026 as part of Amneal’s purchase of 100% of Kashiv BioSciences, LLC membership interests. Deal consideration included $375,000,000 in cash (subject to purchase price adjustments) and 28,942,098 Amneal Class A shares. Following this transaction, entities associated with Patel held 61,341,678 Class A shares indirectly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 12,763,469 shares
Net Buy
1 txn
Insider
Patel Tushar Bhikhubhai
Role
10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock F1 | 12,763,469 | -- | -- |
Holdings After Transaction:
Class A Common Stock — 61,341,678 shares (Indirect, By Limited Liability Companies Controlled by Family Trusts)
Footnotes (1)
- F1. On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the "Purchase Agreement"), by and among the Issuer, Kashiv BioSciences, LLC ("Kashiv"), KB Seller Representative, LLC and the equityholders of Kashiv named therein (the "Sellers"), a subsidiary of the Issuer purchased (the "Acquisition") from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock ("Class A Common Stock"). Pursuant to the terms of the Purchase Agreement, a limited liability company managed by the Reporting Person received 12,763,469 shares of Class A Common Stock in the Acquisition.
Key Figures
Shares acquired: 12,763,469 shares
Post-transaction holdings: 61,341,678 shares
Cash consideration for Kashiv: $375,000,000
+1 more
4 metrics
Shares acquired
12,763,469 shares
Class A common stock indirectly acquired on August 10, 2026
Post-transaction holdings
61,341,678 shares
Indirect Class A holdings by entities associated with reporting person after transaction
Cash consideration for Kashiv
$375,000,000
Cash portion of aggregate consideration to acquire 100% of Kashiv BioSciences, LLC
Stock consideration for Kashiv
28,942,098 shares
Amneal Class A shares issued as part of Kashiv BioSciences acquisition consideration
Key Terms
Membership Interest Purchase Agreement, purchase price adjustments, Class A common stock, indirect ownership
4 terms
Membership Interest Purchase Agreement regulatory
"pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026"
A membership interest purchase agreement is a contract used when someone buys an ownership stake in a limited liability company (LLC). It spells out what is being sold, the price, any promises about the business’s condition, and who takes responsibility for debts or legal issues—like a receipt and rulebook for the sale. Investors care because it transfers control, affects future cash flow and liabilities, and can change the value and tax treatment of their investment.
purchase price adjustments financial
"for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments"
Purchase price adjustments are changes made to the agreed sale price of a company after closing to reflect actual financial facts—like cash on hand, debts, or inventory—found when final accounts are prepared. Think of it as the final bill after a home inspection: the buyer and seller settle differences so the price matches reality. For investors, these adjustments affect the true cost, future earnings and cash flow from a deal, and therefore the value of the investment.
Class A common stock financial
"28,942,098 shares of Issuer Class A common stock ("Class A Common Stock")"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
indirect ownership financial
"ownership type is indirect, by limited liability companies controlled by family trusts"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What transaction did Tushar Bhikhubhai Patel report in Amneal (AMRX) on August 10, 2026?
Tushar Bhikhubhai Patel reported indirectly acquiring 12,763,469 shares of Amneal Class A common stock on August 10, 2026, held through limited liability companies controlled by family trusts and tied to the Kashiv BioSciences acquisition.
What were the total consideration terms for Amneal (AMRX) acquiring Kashiv BioSciences, LLC?
Amneal’s subsidiary agreed to acquire 100% of Kashiv BioSciences, LLC membership interests for $375,000,000 in cash, subject to purchase price adjustments, plus 28,942,098 shares of Amneal Class A common stock as stock consideration.
Is the reported Amneal (AMRX) Form 4 transaction a market purchase or sale?
The reported Form 4 shows a grant, award, or other acquisition of 12,763,469 shares tied to Amneal’s acquisition of Kashiv BioSciences, rather than an open-market purchase or sale, and is categorized as an indirect ownership transaction.